MJP Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
MJP Associates's LLY Position: Q2 2026 in Review
MJP Associates increased its Eli Lilly (LLY) stake by 2.7% in Q2 2026, buying an estimated $104K and bringing the position to 3,834 shares worth $4.6M. The position accounts for 0.5% of the portfolio, ranked #33.
MJP Associates first reported a position in LLY in Q2 2021 and has held it in 21 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- MJP Associates held 3,834 shares of Eli Lilly worth $4.6M as of Q2 2026.
- MJP Associates bought 102 Eli Lilly shares in Q2 2026, an estimated $104K.
- Eli Lilly made up 0.5% of MJP Associates's portfolio in Q2 2026, its #33 holding.
- MJP Associates first reported a position in Eli Lilly in Q2 2021 and has held it in 21 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on MJP Associates's 13F filing for Q2 2026, filed 11 Aug 2026.